Agentic AI: The shift from R&D to R&P will deliver the first...
The next two years will be defined by a shift from R&D (Research & Development) to R&P (Research & Prediction), facilitated by agentic AI.
Newsletters and Deep Dive digital magazine
The next two years will be defined by a shift from R&D (Research & Development) to R&P (Research & Prediction), facilitated by agentic AI.
An AI that screens for early cognitive impairment by sifting through routine clinical documents has shown its value in a real-world evaluation.
Artificial intelligence (AI) is becoming embedded into the fabric of quality, compliance, and production systems.
November and December saw a number of interesting hires in the wider life sciences sphere, spanning digital health innovations and R&D.
On the sidelines of JPM2026, pharmaphorum spoke with Andrew Beck, co-founder and CEO at PathAI, about AI diagnostics in pathology.
Editor's Picks
Newsletters and Deep Dive
digital magazine